Impact of tuberculosis on maternal and child health
dc.contributor.author | Marais B.J. | |
dc.date.accessioned | 2011-05-15T16:17:00Z | |
dc.date.available | 2011-05-15T16:17:00Z | |
dc.date.issued | 2011 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Note | |
dc.identifier.citation | Journal of Infectious Diseases | |
dc.identifier.citation | 203 | |
dc.identifier.citation | 3 | |
dc.identifier.issn | 00221899 | |
dc.identifier.other | 10.1093/infdis/jiq069 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/14029 | |
dc.subject | nevirapine | |
dc.subject | BCG vaccination | |
dc.subject | CD4 lymphocyte count | |
dc.subject | child | |
dc.subject | disease course | |
dc.subject | dosage schedule comparison | |
dc.subject | fetus death | |
dc.subject | human | |
dc.subject | Human immunodeficiency virus | |
dc.subject | Human immunodeficiency virus infection | |
dc.subject | immunocompromised patient | |
dc.subject | immunostimulation | |
dc.subject | intrauterine growth retardation | |
dc.subject | maternal disease | |
dc.subject | maternal welfare | |
dc.subject | note | |
dc.subject | pregnancy outcome | |
dc.subject | prematurity | |
dc.subject | priority journal | |
dc.subject | risk factor | |
dc.subject | single drug dose | |
dc.subject | T lymphocyte activation | |
dc.subject | tuberculosis | |
dc.subject | vertical transmission | |
dc.subject | virus load | |
dc.subject | virus transmission | |
dc.subject | Adult | |
dc.subject | Child | |
dc.subject | Child Welfare | |
dc.subject | Female | |
dc.subject | HIV Infections | |
dc.subject | Humans | |
dc.subject | Maternal Welfare | |
dc.subject | Pregnancy | |
dc.subject | Pregnancy Complications, Infectious | |
dc.subject | Tuberculosis | |
dc.subject | United Nations | |
dc.subject | World Health | |
dc.title | Impact of tuberculosis on maternal and child health | |
dc.type | Note |